Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescenceBeatriz Morancho(Vall d'Hebron Institut de Recerca), Joaquı́n Arribas(Institució Catalana de Recerca i Estudis Avançats)Breast Cancer ResearchAugust 10, 201510.1186/s13058-015-0619-7Cited by 13SaveCiteExport RISWatch citationsRelated PapersAcquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation|Nature Communications|2021|56Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer|Cancer Research|2022|41